These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24614584)

  • 21. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
    Alhalaweh A; Andersson S; Velaga SP
    Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
    Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compare and contrast the effects of surfactants (PluronicF-127 and CremophorEL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme.
    Haj-Ahmad RR; Elkordy AA; Chaw CS; Moore A
    Eur J Pharm Sci; 2013 Jul; 49(4):519-34. PubMed ID: 23712374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF; Costantino HR; Nguyen PA; Hsu CC
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilisation of proteins via mixtures of amino acids during spray drying.
    Ajmera A; Scherließ R
    Int J Pharm; 2014 Mar; 463(1):98-107. PubMed ID: 24412336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constant size, variable density aerosol particles by ultrasonic spray freeze drying.
    D'Addio SM; Chan JG; Kwok PC; Prud'homme RK; Chan HK
    Int J Pharm; 2012 May; 427(2):185-91. PubMed ID: 22322208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
    Grohganz H; Lee YY; Rantanen J; Yang M
    Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pure insulin highly respirable powders for inhalation.
    Balducci AG; Cagnani S; Sonvico F; Rossi A; Barata P; Colombo G; Colombo P; Buttini F
    Eur J Pharm Sci; 2014 Jan; 51():110-7. PubMed ID: 23981336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
    Kumar S; Xu X; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Particle size dependence of polymorphism in spray-dried mannitol.
    Lee YY; Wu JX; Yang M; Young PM; van den Berg F; Rantanen J
    Eur J Pharm Sci; 2011 Sep; 44(1-2):41-8. PubMed ID: 21699976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characterisation of terbutaline sulphate particles prepared by thermal ink-jet spray freeze drying.
    Sharma G; Mueannoom W; Buanz AB; Taylor KM; Gaisford S
    Int J Pharm; 2013 Apr; 447(1-2):165-70. PubMed ID: 23454848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
    van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
    Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS; Abnous K; Tafaghodi M
    Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.